- Title
- CON: Therapy for a Patient with Platinum–Resistant/Refractory Ovarian Cancer Should Not Be Selected Based on Results of an In Vitro Extreme Drug Sensitivity/Resistance Assay
- Creators
- John Farley - Uniformed Services University of the Health SciencesMichael J. Birrer - Massachusetts General Hospital
- Publication Details
- Clinical ovarian cancer and other gynecologic malignancies, Vol.1(2), pp.99-103
- Publisher
- Elsevier Inc
- Identifiers
- 991005969016002656
- Academic Unit
- Obstetrics & Gynecology
- Language
- English
- Resource Type
- Journal article
Journal article
CON: Therapy for a Patient with Platinum–Resistant/Refractory Ovarian Cancer Should Not Be Selected Based on Results of an In Vitro Extreme Drug Sensitivity/Resistance Assay
Clinical ovarian cancer and other gynecologic malignancies, Vol.1(2), pp.99-103
12/2008
Metrics
1 Record Views